Specific Forms of Substance Misuse Increase Stroke Risk – MPR – eMPR.com
Emerging evidence links cannabis use disorder stroke risk to increased incidence of stroke, especially in younger patients. Clinicians should screen for cannabis use disorder stroke risk when assessing stroke causes. Understanding cannabis use disorder…
Alcohol and Tobacco Are More Damaging Than Marijuana: Clinical Insights
Comparative harm alcohol tobacco cannabis research reveals alcohol and tobacco cause greater population-level damage than marijuana. This evidence supports nuanced patient counseling about relative risks. Clinicians can prioritize substance use…
Vaping Linked to Faster Onset of Cannabis Disorder: Study Insights
A recent study highlights vaping cannabis disorder leads to a faster onset of dependence than other methods. Vaped cannabis reaches the brain more rapidly, increasing addiction risk. Clinicians should counsel patients on vaping cannabis disorder risks…
Pediatricians Warn on Cannabis Exposure Risks and Easy Access in Children
Pediatric cannabis exposure risks are increasing due to easy access to high-potency cannabis products. This exposure can impair brain development, cognition, and emotional regulation in children. Pediatricians stress early screening and education to…
Cannabidiol May Help Treat Severe Alcohol Addiction and Protect the Brain
Cannabidiol alcohol use disorder treatment shows promise in reducing addiction severity and protecting against alcohol-related brain damage. Emerging research highlights CBD's neuroprotective effects and potential as an adjunct therapy. Clinical trials…
Legalizing Marijuana: Public Health Outcomes and Substance Use
This article reviews cannabis legalization public health outcomes, highlighting how recreational and medical use laws lead to different substance use reductions. Understanding these outcomes helps clinicians better assess patient risks and community…
GLP-1s a Viable Option to Treat, Prevent SUDs? – Medscape
GLP-1 receptor agonists substance use disorders may provide clinicians with a novel pharmacological approach to treating addiction. Emerging evidence suggests these agents could reduce the risk of substance use disorders, including cannabis use disorder.…
GLP-1s Show Promise in Treating Addiction – MSN
GLP-1 receptor agonists cannabis use disorder potential is gaining attention as a new pharmacological approach. These agents may reduce reward-seeking behavior linked to addiction. Clinicians should monitor emerging evidence on their use for cannabis…
Research News Roundup: March 12, 2026 – Partnership to End Addiction
This research highlights resident attitudes toward cannabis-free policies in permanent supportive housing. Understanding these attitudes is crucial for clinicians managing substance use and housing stability. The findings inform harm reduction approaches…
Study Highlights Parallels Between Cannabis Use and Alcohol Use Patterns Among Teens
Recent research reveals adolescent cannabis alcohol use patterns mirror those of alcohol consumption among teens. These parallels suggest similar escalation trajectories and social influences. Understanding these patterns aids clinicians in improving…